Citius Pharmaceuticals (CTXR) Stock: Why It's Down Today
Updated Oct 19, 2026, 12:05 PM ET · intraday price
- Trading at $0.44 as of 12:05 PM ET, -3.54% vs the prior close of $0.46.
- Volume 361.61K shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CTXR slides 3.5% to $0.44, a 52-week low, 6 down days in a row. Trading at $0.44 (intraday, 12:05 PM ET), -3.54% vs the prior close of $0.46. Day range $0.44–$0.47, opened at $0.46.
CTXR daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — CTXR slides 3.5% to $0.44, a 52-week low, 6 down days in a row
- Trading at $0.44 (intraday, 12:05 PM ET), -3.54% vs the prior close of $0.46. Day range $0.44–$0.47, opened at $0.46.
- Volume was 361.61K shares, 0.9x its 50-day average of 390.62K.
- Price is -22.6% vs its 50-day average ($0.57) and -34.4% vs its 200-day average ($0.68).
- 52-week range $0.44–$2.19; the current price sits at 0% of that range, 79.7% below the 52-week high.
- That makes 6 straight losses.
Oct 16, 2026 — CTXR ends flat (+0.0%) to $0.46, 5 down days in a row
- Closed at $0.46, +0.00% vs the prior close of $0.46. Day range $0.46–$0.47, opened at $0.46.
- Volume was 140.71K shares, 0.3x its 50-day average of 416.67K — lighter than usual.
- Price is -20.4% vs its 50-day average ($0.58) and -32.2% vs its 200-day average ($0.68).
- 52-week range $0.45–$2.19; today's close sits at 1% of that range, 79.0% below the 52-week high.
- That makes 5 straight losses.
Oct 15, 2026 — CTXR dips 1.1% to $0.46, a 52-week low, 4 down days in a row
- Closed at $0.46, -1.08% vs the prior close of $0.47. Day range $0.46–$0.49, opened at $0.46.
- Volume was 303.10K shares, 0.6x its 50-day average of 514.15K — lighter than usual.
- Price is -20.9% vs its 50-day average ($0.58) and -32.3% vs its 200-day average ($0.68).
- 52-week range $0.45–$2.19; today's close sits at 1% of that range, 79.0% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — CTXR dips 2.3% to $0.47, a 52-week low, 3 down days in a row
- Closed at $0.47, -2.31% vs the prior close of $0.48. Day range $0.45–$0.47, opened at $0.46.
- Volume was 233.60K shares, 0.5x its 50-day average of 515.12K — lighter than usual.
- Price is -20.9% vs its 50-day average ($0.59) and -31.8% vs its 200-day average ($0.68).
- 52-week range $0.45–$2.19; today's close sits at 1% of that range, 78.8% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — CTXR slides 3.4% to $0.48, a 52-week low
- Closed at $0.48, -3.45% vs the prior close of $0.49. Day range $0.46–$0.50, opened at $0.48.
- Volume was 192.80K shares, 0.4x its 50-day average of 517.65K — lighter than usual.
- Price is -19.5% vs its 50-day average ($0.59) and -30.4% vs its 200-day average ($0.68).
- 52-week range $0.46–$2.19; today's close sits at 1% of that range, 78.3% below the 52-week high.
Oct 12, 2026 — CTXR dips 1.2% to $0.49
- Closed at $0.49, -1.20% vs the prior close of $0.50. Day range $0.48–$0.51, opened at $0.49.
- Volume was 119.70K shares, 0.2x its 50-day average of 520.24K — lighter than usual.
- Price is -16.9% vs its 50-day average ($0.59) and -28.1% vs its 200-day average ($0.69).
- 52-week range $0.47–$2.19; today's close sits at 1% of that range, 77.5% below the 52-week high.
Oct 9, 2026 — CTXR rises 2.0% to $0.50
- Closed at $0.50, +2.04% vs the prior close of $0.49. Day range $0.48–$0.51, opened at $0.49.
- Volume was 144.20K shares, 0.3x its 50-day average of 553.46K — lighter than usual.
- Price is -16.1% vs its 50-day average ($0.59) and -27.5% vs its 200-day average ($0.69).
- 52-week range $0.47–$2.19; today's close sits at 2% of that range, 77.2% below the 52-week high.
Oct 8, 2026 — CTXR dips 2.4% to $0.49
- Closed at $0.49, -2.40% vs the prior close of $0.50. Day range $0.48–$0.52, opened at $0.49.
- Volume was 132.40K shares, 0.2x its 50-day average of 572.86K — lighter than usual.
- Price is -18.2% vs its 50-day average ($0.60) and -29.2% vs its 200-day average ($0.69).
- 52-week range $0.47–$2.19; today's close sits at 1% of that range, 77.7% below the 52-week high.
Oct 7, 2026 — CTXR jumps 4.2% to $0.50
- Closed at $0.50, +4.16% vs the prior close of $0.48. Day range $0.49–$0.51, opened at $0.49.
- Volume was 161.70K shares, 0.3x its 50-day average of 575.86K — lighter than usual.
- Price is -16.4% vs its 50-day average ($0.60) and -27.8% vs its 200-day average ($0.69).
- 52-week range $0.47–$2.19; today's close sits at 2% of that range, 77.1% below the 52-week high.
Oct 6, 2026 — CTXR slides 7.5% to $0.48, a 1-month low, 3 down days in a row
- Closed at $0.48, -7.50% vs the prior close of $0.52. Day range $0.48–$0.53, opened at $0.52.
- Volume was 419.10K shares, 0.7x its 50-day average of 571.04K.
- Price is -19.7% vs its 50-day average ($0.60) and -30.9% vs its 200-day average ($0.70).
- 52-week range $0.47–$2.19; today's close sits at 1% of that range, 78.0% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — CTXR dips 2.3% to $0.52, a 1-month low
- Closed at $0.52, -2.26% vs the prior close of $0.53. Day range $0.52–$0.54, opened at $0.52.
- Volume was 132.60K shares, 0.2x its 50-day average of 571.92K — lighter than usual.
- Price is -13.3% vs its 50-day average ($0.60) and -25.6% vs its 200-day average ($0.70).
- 52-week range $0.47–$2.19; today's close sits at 3% of that range, 76.3% below the 52-week high.
Oct 2, 2026 — CTXR dips 1.5% to $0.53
- Closed at $0.53, -1.48% vs the prior close of $0.54. Day range $0.52–$0.55, opened at $0.53.
- Volume was 80.50K shares, 0.1x its 50-day average of 576.64K — lighter than usual.
- Price is -11.3% vs its 50-day average ($0.60) and -24.2% vs its 200-day average ($0.70).
- 52-week range $0.47–$2.19; today's close sits at 4% of that range, 75.7% below the 52-week high.
CTXR bull case vs bear case (from the data)
- No clear positive signal in the price trend, filings or insider data right now.
- Price is -22.6% vs its 50-day average — short-term trend is down.
- Price is -34.4% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $32.54M.
- Share count up 61.4% in a year (dilution).
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
CTXR latest news & SEC filings
Every SEC filing by or about CTXR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.49M
- Diluted EPS: -$0.34 (prior year -$0.80) (loss narrowed vs Jun 30, 2025)
Aug 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form UPLOAD — SEC staff letter to the company
SEC staff letter to the company
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade CTXR
- Last results release: Aug 14, 2026 (8-K Item 2.02). Previous ones: May 15, 2026, Feb 13, 2026, Dec 23, 2025. Based on that rhythm, the next report is likely around Nov 13, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.70% (largest 7.5%).
- Liquidity: about 189.60K shares (≈$84.12K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.44 vs a range of $0.44–$2.19 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:25 on Nov 26, 2024
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Aug 21, 2026; 10-Q Aug 14, 2026; 8-K Aug 14, 2026.
- Share count: 27.45M shares outstanding (Aug 13, 2026), +61.4% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
CTXR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 0.46 | 0.47 | 0.44 | 0.44 | 361.61K |
| Oct 16, 2026 | 0.46 | 0.47 | 0.46 | 0.46 | 141.00K |
| Oct 15, 2026 | 0.46 | 0.49 | 0.46 | 0.46 | 303.10K |
| Oct 14, 2026 | 0.46 | 0.47 | 0.45 | 0.47 | 233.60K |
| Oct 13, 2026 | 0.48 | 0.50 | 0.46 | 0.48 | 192.80K |
| Oct 12, 2026 | 0.49 | 0.51 | 0.48 | 0.49 | 119.70K |
| Oct 9, 2026 | 0.49 | 0.51 | 0.48 | 0.50 | 144.20K |
| Oct 8, 2026 | 0.49 | 0.52 | 0.48 | 0.49 | 132.40K |
| Oct 7, 2026 | 0.49 | 0.51 | 0.49 | 0.50 | 161.70K |
| Oct 6, 2026 | 0.52 | 0.53 | 0.48 | 0.48 | 419.10K |
| Oct 5, 2026 | 0.52 | 0.54 | 0.52 | 0.52 | 132.60K |
| Oct 2, 2026 | 0.53 | 0.55 | 0.52 | 0.53 | 80.50K |
| Oct 1, 2026 | 0.55 | 0.57 | 0.53 | 0.54 | 154.80K |
| Sep 30, 2026 | 0.56 | 0.57 | 0.53 | 0.53 | 127.40K |
| Sep 29, 2026 | 0.55 | 0.56 | 0.55 | 0.56 | 150.30K |
| Sep 28, 2026 | 0.57 | 0.59 | 0.53 | 0.55 | 279.50K |
| Sep 25, 2026 | 0.57 | 0.60 | 0.57 | 0.58 | 65.20K |
| Sep 24, 2026 | 0.57 | 0.58 | 0.56 | 0.57 | 154.40K |
| Sep 23, 2026 | 0.60 | 0.61 | 0.57 | 0.57 | 223.10K |
| Sep 22, 2026 | 0.57 | 0.61 | 0.57 | 0.60 | 214.90K |
About Citius Pharmaceuticals
Citius Pharmaceuticals (CTXR) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CRANFORD, NJ. State of incorporation: NV. Fiscal year ends September 30. SEC CIK 1506251.
CTXR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
CTXR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Sep 30, 2023 | — | $-32.54M | -5.57 | $-29.06M |
| Sep 30, 2022 | — | $-33.64M | -0.23 | $-28.36M |
| Sep 30, 2021 | — | $-23.05M | -0.23 | $-24.25M |
| Sep 30, 2020 | — | $-17.55M | — | — |
| Sep 30, 2019 | — | $-15.56M | — | — |
Latest balance sheet: total assets $142.26M, total liabilities $66.35M, cash $17.01M (as of Jun 30, 2026).
CTXR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 14, 2026 | 8-K Item 2.02 (results) | $0.76 |
| May 15, 2026 | 8-K Item 2.02 (results) | $0.70 |
| Feb 13, 2026 | 8-K Item 2.02 (results) | $0.76 |
| Dec 23, 2025 | 8-K Item 2.02 (results) | $1.04 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $1.30 |
| May 14, 2025 | 8-K Item 2.02 (results) | $0.94 |
| Dec 27, 2024 | 8-K Item 2.02 (results) | $3.68 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Feb 15, 2024 | 8-K Item 2.02 (results) | — |
| Jan 2, 2024 | 8-K Item 2.02 (results) | — |
| Aug 15, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on CTXR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 19, 2026, 12:05 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.